Clostridial toxins for treating eye disorders

Details for Australian Patent Application No. 2004249132 (hide)

Owner Allergan, Inc.

Inventors First, Eric R.

Agent Davies Collison Cave

Pub. Number AU-A-2004249132

PCT Pub. Number WO2004/112830

Priority 10/442,590 20.05.03 US

Filing date 17 May 2004

Wipo publication date 29 December 2004

International Classifications

A61K 038/48 Medicinal preparations containing peptides

A61P 027/02 Drugs for disorders of the senses

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/112830 Priority application(s): WO2004/112830

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249133-High titer recombinant influenza viruses for vaccines and gene therapy

2004249125-Compositions and methods for the diagnosis and treatment of tumors of glial origin